Oct 18 (Reuters) - Recce Pharmaceuticals Ltd (RCE) :
- RECCE 327 SARS-COV-2 STUDY UPDATE
- AUSTRALIAN SARS-COV-2 STUDIES CONCLUDES BY MUTUAL AGREEMENT
- RECCE 327 (R327) SHOWN TO SIGNIFICANTLY REDUCE SARS-COV-2 IN HAMSTERS
News: RCE Recce Pharmaceuticals Updates on Recce 327 Sars-Cov-2 Study
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
63.5¢ |
Change
-0.035(5.22%) |
Mkt cap ! $129.5M | |||
| Open | High | Low | Value | Volume |
| 67.0¢ | 67.0¢ | 63.5¢ | $40.07K | 61.58K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 23136 | 63.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 65.0¢ | 20000 | 1 |
View Market Depth
| Last trade - 16.10pm 29/04/2024 (20 minute delay) ? |
|
|||||
|
Last
64.5¢ |
Change
-0.035 ( 2.27 %) |
||||
| Open | High | Low | Volume | ||
| 65.5¢ | 65.5¢ | 63.5¢ | 13498 | ||
| Last updated 15.59pm 29/04/2024 ? | |||||
| RCE (ASX) Chart |